Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
about
A novel strategy for evasion of NK cell immunity by tumours expressing core2 O-glycansLoss of tumor progression locus 2 (tpl2) enhances tumorigenesis and inflammation in two-stage skin carcinogenesisCurrent and Future Gene Therapy for Malignant GliomasAntiangiogenic gene therapy of cancer: recent developmentsIL-12 Production Induced by Agaricus blazei Fraction H (ABH) Involves Toll-like Receptor (TLR)Novel immunotherapeutic approaches to the treatment of urothelial carcinomaCytokine-Induced Modulation of Colorectal CancerInterleukin 12: still a promising candidate for tumor immunotherapy?In-situ tumor vaccination: Bringing the fight to the tumorGenetic engineering with T cell receptorsSignal transducer and activator of transcription 4 in liver diseasesUstekinumab in treatment of Crohn's disease: design, development, and potential place in therapyPD-1 inhibition and treatment of advanced melanoma-role of pembrolizumabReview: Application of Nanoparticles in Urothelial Cancer of the Urinary BladderA novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cellsMirtazapine inhibits tumor growth via immune response and serotonergic systemMathematical modeling of interleukin-27 induction of anti-tumor T cells responseImmune response of healthy horses to DNA constructs formulated with a cationic lipid transfection reagentFocused ultrasound-induced blood-brain barrier opening to enhance interleukin-12 delivery for brain tumor immunotherapy: a preclinical feasibility study.Role of CXCR3 ligands in IL-7/IL-7R alpha-Fc-mediated antitumor activity in lung cancer.Construction of a regulable gene therapy vector targeting for hepatocellular carcinoma.Cloning and characterization of an adenoviral vector for highly efficient and doxycycline-suppressible expression of bioactive human single-chain interleukin 12 in colon cancer.Combining cytotoxic and immune-mediated gene therapy to treat brain tumorsIL-12 can target human lung adenocarcinoma cells and normal bronchial epithelial cells surrounding tumor lesions.Non-redundant role for IL-12 and IL-27 in modulating Th2 polarization of carcinoembryonic antigen specific CD4 T cells from pancreatic cancer patientsEnhanced antitumor effects by combining an IL-12/anti-DNA fusion protein with avelumab, an anti-PD-L1 antibody.Expression, engineering and characterization of the tumor-targeting heterodimeric immunocytokine F8-IL12.Tumor Therapy Applying Membrane-bound Form of Cytokines.The role of interleukin-12 in preserving the graft-versus-leukemia effect of allogeneic CD8 T cells independently of GVHD.IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.The immunocytokine NHS-IL12 as a potential cancer therapeuticStrategy of liver-directed gene therapy: present status and future prospects.Rapid release of cytoplasmic IL-15 from tumor-associated macrophages is an initial and critical event in IL-12-initiated tumor regression.Additive antitumoral effect of interleukin-12 gene therapy and chemotherapy in the treatment of urothelial bladder cancer in vitro and in vivo.Immunomodulation by thalidomide and thalidomide analoguesDual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells.IL-23/IL-27 Ratio in Peripheral Blood of Patients with Breast Cancer.Construction of a single-chain interleukin-12-expressing retroviral vector and its application in cytokine gene therapy against experimental coccidioidomycosis.The role of interleukin-12 and interferon-gamma in GVHD and GVL.Increased levels of C-C chemokine RANTES in asbestos exposed workers and in malignant mesothelioma patients from an hyperendemic area.
P2860
Q24308236-45653C64-9CB7-4996-894C-4A94BC098082Q24633009-33D11E20-DB43-4333-A90E-442AD98ED22AQ24792748-5F2583E7-C5F5-4D53-8FEE-181CAE5FA7B5Q24803786-6675424D-191B-42FD-8AC9-C0BB03ED7F7DQ24808841-213D89F9-5870-46CC-B70B-664099C59DFAQ26744347-5411157E-3257-4401-9E68-082740AE01EBQ26752374-1CC1ED26-2F98-49E8-B324-73FEE23FC6ACQ26861559-592A0DBC-699F-4603-9808-5807B237CAC4Q26991976-4A925E9D-8166-44B4-BB1A-60113314DD71Q26995677-04F3B527-820C-4C24-A391-489EF3209CE5Q27016571-44CA89A9-89FC-45F5-9203-1798968389D3Q28067631-716CE6BD-D9E9-4E8B-B5DC-6423FBEE7DB9Q28073874-B66EBD17-3D4C-4ABD-B8FE-320EC8B2B54FQ28386921-C4F281C5-EF56-47D6-81F4-8727B938DB39Q28476155-CFB6DCA5-3D60-428D-85F3-7597B1BC6166Q28481311-4F515294-A5B0-4AE5-BEBA-32FCC9BE4A85Q28540939-A2832D22-1E2A-47BC-8547-4D5334B84159Q28648083-C202E94D-98A1-4664-A221-D1D2785BF31AQ30416228-E52A41FF-EEC6-404D-8441-194FD206CF2DQ30426606-1F532FE7-2D5E-443A-A3A3-1E687985465FQ30724968-19CD5C21-8646-4236-BE5B-19555DE5C57EQ30832187-3B44EE50-6D82-409A-9BFA-878D466A58F5Q31013320-68F8F7F2-4D44-42DB-B14B-9DC8785825B3Q33479161-DA3CDF6E-4EF7-443B-81E0-EE9F810F3C5EQ33508227-71B1032E-9B0D-4E13-AF2A-04849E844D89Q33591239-0DDED6D1-863A-4EEC-A9DE-672DB2E11B20Q33605532-8974568A-4278-4833-A233-E3EB8ABE84C4Q33631960-E82A1B5A-B126-44EF-9AFF-A7EE0EB4B58BQ33643965-79DCA02D-A6EF-4B57-A992-527F62FD7819Q33670036-10CB8C9F-6E3D-43FE-A2B0-94D78AFD3BF7Q33688398-63A4882D-FA72-48E7-AB6E-354355903625Q33718826-184BFEBE-3AF2-4DC5-AA0C-84C1113B0D4DQ33738154-D80035DE-0EF3-4ECA-B5C1-319F1259442BQ33745353-B801EF57-3859-43C4-A07B-0697CD82C8F6Q33782386-5DAB8E0B-ABB3-49A6-9179-B1331C5A5544Q33890583-87E0AB4C-E305-4D66-A4DF-606D68CE5C0BQ33907311-12A74AC0-8E19-4ACD-827D-AFD6A6E7332FQ34001166-55EC8A8D-07A7-4D2F-8301-93F887595130Q34025160-CCC19CC7-000C-4F4B-A67A-70E270A1B877Q34097257-E6EB75DC-EC8A-41E2-B7B0-148ACF955B8F
P2860
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年論文
@yue
1993年論文
@zh-hant
1993年論文
@zh-hk
1993年論文
@zh-mo
1993年論文
@zh-tw
1993年论文
@wuu
1993年论文
@zh
1993年论文
@zh-cn
name
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
@en
type
label
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
@en
prefLabel
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
@en
P2093
P2860
P356
P1476
Antitumor and antimetastatic activity of interleukin 12 against murine tumors.
@en
P2093
Hubbard BR
Warrier RR
P2860
P304
P356
10.1084/JEM.178.4.1223
P407
P577
1993-10-01T00:00:00Z